AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14585449 — intervention group
Group type: COMPARATOR
Intervention: Antacid + Donnatal + viscous lidocaine (Group 3)
Number of subjects: 120
Study 10634370 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg/day)
Number of subjects: 40
Study 10634370 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg/day)
Number of subjects: 40
Study 10634370 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg/day)
Number of subjects: 40
Study 10634370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9039715 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone suleptanate
Number of subjects: 88
Study 9039715 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate
Number of subjects: 88
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: BHAC-DMP + VCR 0.35 mg/m2 on days 1-4
Number of subjects: 258
Study 1578954 — intervention group
Group type: COMPARATOR
Intervention: BHAC-DMP
Number of subjects: 258
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy of 12 courses
Number of subjects: 258
Study 1578954 — intervention group
Group type: COMPARATOR
Intervention: Maintenance therapy of 4 courses
Number of subjects: 258
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 258
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS)
Number of subjects: 258
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing CR rate
Number of subjects: 258
Study 1578954 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-free survival (DFS)
Number of subjects: 258
Study 2579801 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed words (preceded by a semantically related word)
Number of subjects: 0
Study 2579801 — intervention group
Group type: COMPARATOR
Intervention: Unprimed words (preceded by semantically unrelated words or nonwords)
Number of subjects: 0
Study 2579801 — intervention group
Group type: EXPERIMENTAL
Intervention: ERPs for primed words
Number of subjects: 0
Study 2579801 — intervention group
Group type: COMPARATOR
Intervention: ERPs for unprimed words
Number of subjects: 0
Study 2579801 — intervention group
Group type: EXPERIMENTAL
Intervention: P300 latency
Number of subjects: 0
Study 30541074 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial peak reservoir strain (LA RS)
Number of subjects: 385
Study 27869485 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (90-min sessions, twice a week for 8 weeks)
Number of subjects: 40
Study 27869485 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 40
Study 27869485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga)
Number of subjects: 40
Study 27303937 — intervention group
Group type: EXPERIMENTAL
Intervention: Biangulation technique
Number of subjects: 32
Study 27303937 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangulation technique
Number of subjects: 32
Study 24485056 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational offsets of 1°, 3°, and 5° in roll, yaw, and pitch
Number of subjects: 11
Study 22897901 — intervention group
Group type: EXPERIMENTAL
Intervention: TeamCare intervention
Number of subjects: 168
Study 22897901 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 19249048 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 microg of rectal misoprostol
Number of subjects: 514
Study 19249048 — intervention group
Group type: COMPARATOR
Intervention: 5 IU of intravenous oxytocin
Number of subjects: 514
Study 17432679 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus rehabilitation training (Bobath and Vojta methods)
Number of subjects: 100
Study 17432679 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training (Bobath and Vojta methods)
Number of subjects: 100
Study 14747203 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-based strategy (glycemia plus ultrasound)
Number of subjects: 199
Study 14747203 — intervention group
Group type: COMPARATOR
Intervention: Standard management (maternal glycemia alone)
Number of subjects: 199
Study 11498311 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 mg/kg rocuronium
Number of subjects: 51
Study 11498311 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg/kg atracurium
Number of subjects: 51
Study 9662821 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin, 500 mg orally twice a day for 15-14 days
Number of subjects: 61
Study 9662821 — intervention group
Group type: COMPARATOR
Intervention: Combination of recombinant alpha 2‐interferon with complex immunoglobulin preparation (CTP), vaginal suppositories containing 300 mg of CTP and intravaginal application of 15(2)-30 ml of solution containing 2.0 x 10(6) I.U. of recombinant alpha 2‐interferon
Number of subjects: 61
Study 9662821 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 61
Study 9662821 — intervention group
Group type: COMPARATOR
Intervention: Combination of recombinant alpha 2‐interferon with complex immunoglobulin preparation (CTP)
Number of subjects: 61
Study 7810790 — intervention group
Group type: EXPERIMENTAL
Intervention: Over the top graft placement
Number of subjects: 87
Study 7810790 — intervention group
Group type: EXPERIMENTAL
Intervention: Through the femoral condyle graft placement
Number of subjects: 87
Study 7810790 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 87
Study 3276298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 14
Study 3276298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 3276298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (after placebo group received it)
Number of subjects: 14
Study 3276298 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of all patients receiving cyclophosphamide
Number of subjects: 14
Study 30864000 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema training at the outset of learning
Number of subjects: 0
Study 30864000 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ratio of worked examples to problem-solving practice
Number of subjects: 0
Study 30864000 — intervention group
Group type: COMPARATOR
Intervention: Schema training after problem-solving practice
Number of subjects: 0
Study 30864000 — intervention group
Group type: COMPARATOR
Intervention: Lower ratio of worked examples to problem-solving practice
Number of subjects: 0
Study 29587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-elbow cast (AE)
Number of subjects: 128
Study 29587687 — intervention group
Group type: COMPARATOR
Intervention: Below-elbow cast (BE)
Number of subjects: 128
Study 28028319 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention involving motivational interviews with parents and teacher-led learning experiences for children.
Number of subjects: 425
Study 28028319 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 425
Study 28028319 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (I).
Number of subjects: 425
Study 28028319 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI outcomes (I).
Number of subjects: 425
Study 26039952 — intervention group
Group type: EXPERIMENTAL
Intervention: Limberg flap technique
Number of subjects: 71
Study 26039952 — intervention group
Group type: COMPARATOR
Intervention: Karydakis flap technique
Number of subjects: 71
Study 24134550 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 78
Study 24134550 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 78
Study 24134550 — intervention group
Group type: COMPARATOR
Intervention: Control (Healthy men)
Number of subjects: 78
Study 24134550 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin and Pioglitazone
Number of subjects: 78
Study 21318734 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet Eye (QE) training
Number of subjects: 20
Study 21318734 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (no instruction)
Number of subjects: 20
Study 19884428 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 86
Study 19884428 — intervention group
Group type: COMPARATOR
Intervention: Nonresurfacing of the patella
Number of subjects: 86
Study 16504859 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-engineered bone (autogenous osteoblasts cultured on demineralized bone matrix Osteovit)
Number of subjects: 20
Study 16504859 — intervention group
Group type: COMPARATOR
Intervention: Spongiose iliac bone
Number of subjects: 20
Study 15299049 — intervention group
Group type: EXPERIMENTAL
Intervention: Image fusion of CT and PET
Number of subjects: 104
Study 15299049 — intervention group
Group type: COMPARATOR
Intervention: CT alone
Number of subjects: 104
Study 15299049 — intervention group
Group type: COMPARATOR
Intervention: PET alone
Number of subjects: 104
Study 10884648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion at 1 microg. kg(‐1). min(‐1) starting 10 minutes before cardiopulmonary bypass and maintained for 4 hours
Number of subjects: 20
Study 10884648 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 20
Study 10884648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion
Number of subjects: 20
Study 9605251 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational age at delivery
Number of subjects: 353
Study 9605251 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of painful labor
Number of subjects: 353
Study 9605251 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of antenatal antibiotic therapy
Number of subjects: 353
Study 9605251 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 353
Study 9605251 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor X activity in umbilical cord blood
Number of subjects: 353
Study 9605251 — intervention group
Group type: COMPARATOR
Intervention: Mode of delivery
Number of subjects: 353
Study 9605251 — intervention group
Group type: COMPARATOR
Intervention: Cord blood acid-base status
Number of subjects: 353
Study 9605251 — intervention group
Group type: COMPARATOR
Intervention: Coagulation status
Number of subjects: 353
Study 8350001 — intervention group
Group type: EXPERIMENTAL
Intervention: Layered closure technique
Number of subjects: 34
Study 8350001 — intervention group
Group type: COMPARATOR
Intervention: Mass closure technique
Number of subjects: 34
Study 2873967 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral astemizole (30 mg during the first week, then 10 mg for the rest of the study period)
Number of subjects: 95
Study 2873967 — intervention group
Group type: COMPARATOR
Intervention: Topical sodium cromoglycate (2%, administered 6-times daily intranasally and 4-times daily in the eyes)
Number of subjects: 95
Study 31783231 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhang's guideline
Number of subjects: 7277
Study 31783231 — intervention group
Group type: COMPARATOR
Intervention: WHO partograph
Number of subjects: 7277
Study 30194500 — intervention group
Group type: EXPERIMENTAL
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 163
Study 30194500 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG)
Number of subjects: 163
Study 28161387 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24IU)
Number of subjects: 30
Study 28161387 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (20IU)
Number of subjects: 30
Study 28161387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 26419824 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone plus Misoprostol
Number of subjects: 110
Study 26419824 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 110
Study 23451243 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (PROP) 80 mg administered 60 minutes prior to stress exposure
Number of subjects: 30
Study 23451243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 30
Study 23451243 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (PROP)
Number of subjects: 30
Study 21336835 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (100 μg, single intramuscular dose)
Number of subjects: 240
Study 21336835 — intervention group
Group type: COMPARATOR
Intervention: Syntometrine (single intramuscular dose)
Number of subjects: 240
Study 19172538 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (0.625 mg) plus methyl-testosterone (1.25 mg) and micronised progesterone (100 mg)
Number of subjects: 40
Study 19172538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16246545 — intervention group
Group type: COMPARATOR
Intervention: CPT‐11 administered at 180 mg/m2 on day 1, by 1‐h infusion (Arm A)
Number of subjects: 68
Study 16246545 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐h sinusoidal infusion of CPT‐11 with peak timing at 5:00 a.m. (Arm B)
Number of subjects: 68
Study 14677160 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: actual LPLT (5 minutes, 3 J total dose + exercise)
Number of subjects: 90
Study 14677160 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: actual LPLT (3 minutes, 2 J total dose + exercise)
Number of subjects: 90
Study 14677160 — intervention group
Group type: COMPARATOR
Intervention: Group III: placebo laser group + exercise
Number of subjects: 90
Study 11020511 — intervention group
Group type: EXPERIMENTAL
Intervention: DSG 150-T 100
Number of subjects: 24
Study 11020511 — intervention group
Group type: EXPERIMENTAL
Intervention: DSG 300-T 100
Number of subjects: 24
Study 11020511 — intervention group
Group type: COMPARATOR
Intervention: DSG 150-T 100, DSG 300-T 100, LNG 125-T 100
Number of subjects: 24
Study 11020511 — intervention group
Group type: COMPARATOR
Intervention: DSG 300-T 100, LNG 125-T 100
Number of subjects: 24
Study 8835876 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive agents
Number of subjects: 0
Study 8835876 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional medical regimens
Number of subjects: 0
Study 1413847 — intervention group
Group type: COMPARATOR
Intervention: Bilateral subtotal resection (n = 23)
Number of subjects: 50
Study 1413847 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemithyroidectomy plus contralateral resection (n = 27)
Number of subjects: 50
Study 2982882 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with vincristin, methotrexate, and cyclophosphamide
Number of subjects: 79
Study 2982882 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with vincristin, methotrexate, and cyclophosphamide plus systemic immunotherapy with Propionibacterium granulosum strain KP-45
Number of subjects: 79
Study 2982882 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 79
Study 31497011 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron sucrose (non-dialysis group)
Number of subjects: 83
Study 31497011 — intervention group
Group type: COMPARATOR
Intervention: Ferric carboxymaltose (non-dialysis group)
Number of subjects: 83
Study 31497011 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron sucrose (dialysis group)
Number of subjects: 83
Study 31497011 — intervention group
Group type: COMPARATOR
Intervention: No IV iron (dialysis group)
Number of subjects: 83
Study 31497011 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron (both groups)
Number of subjects: 83
Study 29059068 — intervention group
Group type: EXPERIMENTAL
Intervention: Armeo robotic therapy (12 weeks, 45 min/session, 3 days/week)
Number of subjects: 30
Study 29059068 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (12 weeks)
Number of subjects: 30
Study 26935357 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 660
Study 26935357 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 660
Study 26935357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 660
Study 26935357 — intervention group
Group type: COMPARATOR
Intervention: Focal/grid laser photocoagulation
Number of subjects: 660
Study 26935357 — intervention group
Group type: COMPARATOR
Intervention: Baseline VA worse (20/50 to 20/320)
Number of subjects: 660
Study 26935357 — intervention group
Group type: COMPARATOR
Intervention: Baseline VA better (20/32 to 20/40)
Number of subjects: 660
Study 25028689 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraEZ (KNO3)
Number of subjects: 102
Study 25028689 — intervention group
Group type: EXPERIMENTAL
Intervention: MI Paste (CPP-ACP)
Number of subjects: 102
Study 25028689 — intervention group
Group type: COMPARATOR
Intervention: Placebo of UltraEZ
Number of subjects: 102
Study 25028689 — intervention group
Group type: COMPARATOR
Intervention: Placebo of MI Paste
Number of subjects: 102
Study 25028689 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraEZ and MI Paste
Number of subjects: 102
Study 22469559 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib-melphalan-prednisone (VMP; nine 6-wk cycles)
Number of subjects: 0
Study 22469559 — intervention group
Group type: COMPARATOR
Intervention: Melphalan-prednisone (MP)
Number of subjects: 0
Study 22469559 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib dose intensity
Number of subjects: 0
Study 20634754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-intensity interval endurance training (MI-ET)
Number of subjects: 13
Study 20634754 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit-interval resistance training (CRT)
Number of subjects: 13
Study 20634754 — intervention group
Group type: COMPARATOR
Intervention: Traditional continuous endurance training (ET)
Number of subjects: 13
Study 17693373 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive self-ligating SmartClip brackets
Number of subjects: 19
Study 17693373 — intervention group
Group type: COMPARATOR
Intervention: Conventional twin brackets ligated with stainless steel ligatures
Number of subjects: 19
Study 15780117 — intervention group
Group type: EXPERIMENTAL
Intervention: Predilution hemodiafiltration (HDF)
Number of subjects: 12
Study 15780117 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis
Number of subjects: 12
Study 12372680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0
Study 12372680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11887892 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated push-pull effect (PPE) test with head-up stand (HUT, +1 Gz) for 1 min, head-down stand (HDT, -1 Gz) for 30 s, and HUT combining LBNP (-50 mmHg) for 10 min.
Number of subjects: 8
Study 11887892 — intervention group
Group type: COMPARATOR
Intervention: Control test with HUT combining LBNP (-50 mmHg) for 10 min.
Number of subjects: 8
Study 9620386 — intervention group
Group type: EXPERIMENTAL
Intervention: Premier E. coli O157
Number of subjects: 876
Study 9620386 — intervention group
Group type: EXPERIMENTAL
Intervention: Premier EHEC
Number of subjects: 876
Study 9620386 — intervention group
Group type: COMPARATOR
Intervention: Standard culture (control)
Number of subjects: 876
Study 9620386 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-O157 verotoxin-producing E. coli
Number of subjects: 876
Study 8141435 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (5 mg/kg body weight intravenous infusion over 20 min, followed by 1 mg/kg per hour)
Number of subjects: 20
Study 8141435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8141435 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline at subtherapeutic concentrations (5 micrograms/ml)
Number of subjects: 20
Study 2449871 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 29
Study 2449871 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 29
Study 31296328 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative rectal tube for 5 days (Group A)
Number of subjects: 383
Study 31296328 — intervention group
Group type: COMPARATOR
Intervention: No postoperative rectal tube (Group B)
Number of subjects: 383
Study 29606547 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (20-45 min walking or running at 50-70% of heart rate reserve, 3 sessions per week for 12 weeks)
Number of subjects: 24
Study 29606547 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 24
Study 29606547 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 24
Study 29079227 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel chemotherapy
Number of subjects: 0
Study 29079227 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone
Number of subjects: 0
Study 29079227 — intervention group
Group type: COMPARATOR
Intervention: Conventional androgen deprivation
Number of subjects: 0
Study 25920503 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented treadmill-walking training (TOTWT)
Number of subjects: 0
Study 25920503 — intervention group
Group type: COMPARATOR
Intervention: Conventional treadmill-walking training (CTWT)
Number of subjects: 0
Study 22570252 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Navigation (DN)
Number of subjects: 123
Study 22570252 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 123
Study 21511276 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2216684 6-18 mg once daily
Number of subjects: 495
Study 21511276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study 17956931 — intervention group
Group type: COMPARATOR
Intervention: Minimal Intervention Bibliotherapy Treatment (MIT)
Number of subjects: 117
Study 17956931 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session parenting program led by a nurse or psychologist
Number of subjects: 117
Study 17199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal thermometry (DT) with a skin temperature differential of > or =10 degrees F at baseline
Number of subjects: 332
Study 17199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal thermometry (DT) with a skin temperature differential of <10 degrees F at baseline
Number of subjects: 332
Study 17199766 — intervention group
Group type: COMPARATOR
Intervention: Baseline skin temperature differential
Number of subjects: 332